NETWORKING SESSION: From Proteins to Predictions: Translating high throughput proteomics into clinical cancer risk scores


Date: 8th November 2022, Tuesday

Time: 1.00 PM – 2.00 PM Singapore

Venue: Level 5, Seminar Room 5, Lee Kong Chien School Of Medicine (Novena Campus)

Limited Seats, Register Now

Stand a chance to win an Apple iPad Air at the Networking Session. Hurry, register now!

We’re thrilled to invite you to our SomaLogic Networking Session at the Frontiers in Cancer Science 2022. Dr. Tala Khosroheidari, Director of Global Scientific Engagement at SomaLogic, will discuss how proteomics technologies, such as SomaScan®, have advanced the field to not only be a tool for biomarker discovery, but also allow acceleration of drug development, clinical trials, and transforming precision medicine.

Learn more about some of the research studies Tala discusses and the application of omics in studying disease below:

  1. Diabetes 
  2. Immuno-oncology 
  3. Cardiovascular
  4. NASH and the SomaScan® Platform

Visit Us at Booth E8.2

Stop by Exhibitor Booth E8.2 at Level 8 MPH during 7th – 9th November 2022: Frontiers in Cancer Science 2022 to pick up our newest literature including our SomaScan Discovery and SomaScan Panels brochures. Don’t miss out on exclusive SomaLogic and Genomax giveaways.

Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Us
close slider